As part of a subgroup analysis on the different monotherapy treatment regimes, we also found that the class of anti-PD-1 and anti-CTLA-4 had elevated hazard ratios associated with uveitis development compared to their non-ICI comparators. The gene discussed is CTLA4; the disease is uveitis.